Chicago Atlantic BDC Inc

Chicago Atlantic BDC Inc(LIEN)股票分析

$9.200

+0.101 (+1.10%)收盤時

Loading chart…
最高
9.250
開盤
9.110
成交量加權均價
9.19
成交量
17.50K
市值
—
最低
9.110
成交金額
160.80K
企業價值/稅息折舊攤銷前利潤(TTM)
-0.23

Chicago Atlantic BDC, Inc. is a specialty finance company. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. It has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The Company may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors.

AI 分析 of Chicago Atlantic BDC Inc (LIEN)

持有

While LIEN has a strong dividend yield of 13.19% and a forward P/E ratio of 5.58, indicating potential value, the stock has underperformed with a year-to-date change of -11.98% and a recent RSI of 42.22, suggesting it is nearing oversold territory but not yet a strong buy signal. The main risk is the recent decline in net income to common shareholders, which dropped to $6,064,079 in Q2 2026 from $8,534,388 in Q1 2026, indicating potential profitability concerns.

估值指標

Chicago Atlantic BDC Inc(LIEN)目前預期本益比為 5.61,5 年平均預期本益比為 6.58。

預期本益比

低估
5 年均值 P/E
6.58
目前P/E
5.61
高估
7.18
低估
5.98

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
84.70
目前EV/EBITDA
-0.23
高估
282.91
低估
-113.51

預期股價營收比

低估
5 年均值 P/S
3.32
目前P/S
3.07
高估
3.53
低估
3.12

Alphio AI 對 LIEN 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%LIEN

$10.25

情境價格

基

基準

基準 · 50%LIEN

$9.62

情境價格

悲

悲觀

悲觀 · 25%LIEN

$7.94

情境價格

事件時間軸

2026-05-11 (ET)

16:20:00

Chicago Atlantic BDC Files for $500M Securities Registration

2026-03-19 (ET)

07:10:00

Chicago Atlantic BDC Reports $14.2M Investment Income

2025-11-13 (ET)

07:15:20

Chicago Atlantic BDC Announces Q3 NII per Share of 42 Cents, Up from 34 Cents Last Quarter

2025-08-14 (ET)

07:07:36

Chicago Atlantic BDC reports Q2 NII 34c vs. 38c last year

2025-05-14 (ET)

07:14:32

Chicago Atlantic BDC reports Q1 EPS 33c vs 35c last year

資訊

LIEN 常見問題 —— 由 Alphio AI 解答

Chicago Atlantic BDC, Inc. is a specialty finance company. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. It has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The Company may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors. It operates in the Financials sector.

While LIEN has a strong dividend yield of 13.19% and a forward P/E ratio of 5.58, indicating potential value, the stock has underperformed with a year-to-date change of -11.98% and a recent RSI of 42.22, suggesting it is nearing oversold territory but not yet a strong buy signal. The main risk is the recent decline in net income to common shareholders, which dropped to $6,064,079 in Q2 2026 from $8,534,388 in Q1 2026, indicating potential profitability concerns.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易